Lucid Diagnostics Inc (LUCD)

NASDAQ

$0.97

Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.

Sector:

Industry:

68 analysts

Strong Buy

Target: $3.95 (+307.51%)

Market Cap

$190M

Free Cash Flow Yield

-24.54%

Beta (5Y)

0.84

Adjust inflation

Log

Valuation

Market Cap$190M

P/S40.69

P/B2.16

Profitability

Total Revenue (TTM)$5.13M

Gross Profit (TTM)-$1.61M

EBITDA-$48M

Operating Margin-964%

EPS-$0.33

Financial Health

Free Cash Flow Yield-24.54%

Growth & Risk

Beta (5Y)0.84

Sharpe Ratio0.02